Acuta Capital Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.9M | Sell |
|
|||||
|
2025
Q1 | $3.64M | Buy |
|
|||||
|
2024
Q4 | $3.16M | Buy |
|
|||||
|
2024
Q3 | $3.14M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $8.21M | Sell |
|
|||||
|
2020
Q1 | $7.12M | Buy |
|
|||||
|
2019
Q4 | $3.13M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $5.07M | Sell |
|
|||||
|
2018
Q2 | $20.7M | Sell |
|
|||||
|
2018
Q1 | $35.6M | Buy |
|
|||||
|
2017
Q4 | $21.3M | Buy |
|
|||||
|
2017
Q3 | $18.1M | Sell |
|
|||||
|
2017
Q2 | $25.7M | Buy |
|
|||||
|
2017
Q1 | $15.4M | Sell |
|
|||||
|
2016
Q4 | $11.6M | Buy |
|
|||||
|
2016
Q3 | $7.3M | Sell |
|
|||||
|
2016
Q2 | $6.27M | Sell |
|
|||||
|
2016
Q1 | $11.6M | Buy |
|
|||||
|
2015
Q4 | $9.51M | Buy |
|
|||||
|
2015
Q3 | $8.32M | Buy |
|
|||||
|
2015
Q2 | $7.46M | Buy |
|
|||||
|
2015
Q1 | $3.97M | Buy |
|